"Having cancer is very expensive": A qualitative study of patients with ovarian cancer and PARP inhibitor treatment. Smith AJB, O'Brien C, Haggerty A, Ko EM, et al. Gynecol Oncol 2024;186:170-175.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Smith AJB, O'Brien C, Haggerty A, Ko EM, et al. "Having cancer is very expensive": A qualitative study of patients with ovarian cancer and PARP inhibitor treatment. Gynecol Oncol 2024;186:170-175.
PMID: 38691987